BACKGROUND: Acute nonarteritic anterior ischemic optic neuropathy (NAION) is considered to be acute ischemia of the posterior ciliary arteries. Prostaglandin E1 (PGE1), a powerful microcirculation vasodilator, has been shown to improve ocular blood flow. DESIGN: A nonrandomized, comparative trial. METHODS: Eight consecutive cases of NAION were treated with intravenous steroids and PGE1. Seven control cases of NAION were treated with acetylsalicylic acid and oral steroids. Fisher's exact test was used for statistical analysis. RESULTS: The visual acuity improved in seven cases of NAION treated with PGE1 and was unchanged in one. Of the seven control cases, four had no change in vision and three lost further visual acuity on follow-up visits. CONCLUSIONS: Intravenous PGE1 and steroids should be considered in cases of NAION to immediately restore blood flow to the optic nerve and improve visual acuity.
BACKGROUND: Acute nonarteritic anterior ischemic optic neuropathy (NAION) is considered to be acute ischemia of the posterior ciliary arteries. Prostaglandin E1 (PGE1), a powerful microcirculation vasodilator, has been shown to improve ocular blood flow. DESIGN: A nonrandomized, comparative trial. METHODS: Eight consecutive cases of NAION were treated with intravenous steroids and PGE1. Seven control cases of NAION were treated with acetylsalicylic acid and oral steroids. Fisher's exact test was used for statistical analysis. RESULTS: The visual acuity improved in seven cases of NAION treated with PGE1 and was unchanged in one. Of the seven control cases, four had no change in vision and three lost further visual acuity on follow-up visits. CONCLUSIONS: Intravenous PGE1 and steroids should be considered in cases of NAION to immediately restore blood flow to the optic nerve and improve visual acuity.
Authors: M R Cesarone; G Belcaro; A N Nicolaides; M Griffin; G Geroulakos; G Ramaswami; M Cazaubon; A Barsotti; S Vasdekis; D Christopoulos; G Agus; P Bavera; P Mondani; E Ippolito; F Flenda Journal: Minerva Cardioangiol Date: 2002-12 Impact factor: 1.347
Authors: G Belcaro; A N Nicolaides; G Agus; M R Cesarone; G Geroulakos; L Pellegrini; M T De Sanctis; L Incandela; A Ricci; P Mondani; R De Angelis; E Ippolito; A Barsotti; S Vasdekis; A Ledda; D Christopoulos; B M Errichi; H Helmis; U Cornelli; G Ramaswami; M Dugall; M Bucci; G Martines; P G Ferrari; M Corsi; D Di Francescantonio Journal: Angiology Date: 2000-08 Impact factor: 3.619
Authors: Robert D Steigerwalt; M Rosaria Cesarone; Gianni Belcaro; Pierpaolo Quercioli; Giorgio Lofoco; Francesco Ciucci; Antonella Pascarella; Mauro De Angelis; Laura Rapagnetta; Marcella Nebbioso Journal: J Ocul Pharmacol Ther Date: 2008-08 Impact factor: 2.671
Authors: G Belcaro; G Laurora; A N Nicolaides; G Agus; M R Cesarone; M T DeSanctis; L Incandela; A Ricci; M Cazaubon; E Ippolito; A Barsotti; S Vasdekis; A Ledda; P Iacobitti; D Christopoulos; B M Errichi; H Helmis; U Cornelli; G Ramaswami; M Bucci; P G Ferrari; M Corsi; P Pomante; L Mezzanotte; G Geroulakos Journal: Angiology Date: 1998-11 Impact factor: 3.619
Authors: Robert D Steigerwalt; M Rosaria Cesarone; Gianni Belcaro; Antonella Pascarella; Mauro De Angelis; Roberto Gattegna; Marcella Nebbioso Journal: Int J Angiol Date: 2010
Authors: Abdullah Al-Kaabi; Agha S Haider; Mohammed O Shafeeq; Mohammed A El-Naggari; Ibtisam El-Nour; Anuradha Ganesh Journal: Sultan Qaboos Univ Med J Date: 2016-11-30
Authors: Robert D Steigerwalt; M Rosaria Cesarone; Gianni Belcaro; Mauro De Angelis; Antonella Pascarella; Marcella Nebbioso Journal: Neuroophthalmology Date: 2011-03-20
Authors: Krisztina Lantos; Zsuzsa Réka Dömötör; Nelli Farkas; Szabolcs Kiss; Zsolt Szakács; András Garami; Gábor Varga; László Lujber; Reem Kanaan; Péter Hegyi; Gergely Fehér; Valéria Gaál Journal: Int J Environ Res Public Health Date: 2022-02-26 Impact factor: 3.390